Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia

Eur J Haematol. 2011 Jun;86(6):548-9. doi: 10.1111/j.1600-0609.2011.01603.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Benzamides
  • Cross Reactions
  • Dasatinib
  • Drug Eruptions / etiology*
  • Drug Eruptions / pathology
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Middle Aged
  • Piperazines / adverse effects*
  • Protein Kinase Inhibitors / adverse effects
  • Pyrimidines / adverse effects*
  • Thiazoles / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • nilotinib
  • Dasatinib